These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 2048592

  • 1. Oral contraceptives and antithrombin III: variations by dosage and ABO blood group.
    Burkman RT, Bell WR, Zacur HA, Kimball AW.
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1453-8; discussion 1458-60. PubMed ID: 2048592
    [Abstract] [Full Text] [Related]

  • 2. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 3. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T, Lindheim SR, Duffy DM, Vijod MA, Stanczyk FZ, Lobo RA.
    Am J Obstet Gynecol; 1993 Dec 01; 169(6):1540-4. PubMed ID: 8267059
    [Abstract] [Full Text] [Related]

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW, Chenault CB, de la Peña A, Dozier TS, Kraemer DC.
    Fertil Steril; 1978 Nov 01; 30(5):522-33. PubMed ID: 214353
    [Abstract] [Full Text] [Related]

  • 5. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov 01; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 6. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA, Demers LM, Applebaum-Bowden D, Lenker R.
    Contraception; 1991 Aug 01; 44(2):113-24. PubMed ID: 1893706
    [Abstract] [Full Text] [Related]

  • 7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Aug 01; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 8. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K, Sami G, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun 01; 5(1):19-24. PubMed ID: 12256026
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptives, anti-thrombin III and fibrinolytic activity in Africans.
    Greig HB.
    Acta Haematol; 1977 Jun 01; 58(3):138-44. PubMed ID: 409028
    [Abstract] [Full Text] [Related]

  • 10. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Jun 01; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 11. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I, Zaki K, Rashad S.
    Egypt Popul Fam Plann Rev; 1972 Jun 01; 5(1):67-77. PubMed ID: 12256028
    [Abstract] [Full Text] [Related]

  • 12. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL, Roy S, Lobo RA.
    Contraception; 1984 Apr 01; 29(4):319-24. PubMed ID: 6235099
    [Abstract] [Full Text] [Related]

  • 13. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL, Bariso CD, Yuliano E, Hume RJ, Pasquale SA.
    Contraception; 1975 Mar 01; 11(3):329-38. PubMed ID: 1116369
    [Abstract] [Full Text] [Related]

  • 14. Adrenocortical function of patients using oral contraceptives.
    Kauppila A, Järvinen PA, Ylöstalo P, Reinilä M.
    Acta Obstet Gynecol Scand; 1974 Mar 01; 53(2):155-9. PubMed ID: 4362662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E, Hemmingsen L, Møller KJ, Serup J, Weber T.
    Acta Endocrinol (Copenh); 1978 Apr 01; 87(4):855-64. PubMed ID: 347855
    [Abstract] [Full Text] [Related]

  • 18. Liver function tests in patients on oral progestogens.
    Engineer AD, Gupta V, Tandon P.
    J Obstet Gynaecol India; 1968 Apr 01; 18(2):598-605. PubMed ID: 12331828
    [Abstract] [Full Text] [Related]

  • 19. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
    Basdevant A, Conard J, Pelissier C, Guyene TT, Lapousterle C, Mayer M, Guy-Grand B, Degrelle H.
    Contraception; 1993 Sep 01; 48(3):193-204. PubMed ID: 8222650
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats.
    Liu HF, Magdalou J, Nicolas A, Lafaurie C, Siest G.
    Gen Pharmacol; 1991 Sep 01; 22(2):393-7. PubMed ID: 1905251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.